BIOTELEMETRY, INC.
DelistedCIK 1574774fmd_08EAQ7MWYEMS99QM0736B53DW0Services · Services-Specialty Outpatient Facilities, NECTemplate: Standard
Coverage: Jan 01, 2011 to Sep 30, 2020, 36 periods
Latest annual · FY2019
Millions- Total revenues
- 439
- Gross profit
- 274
- Operating income
- 53
- Net income
- 30
- Free cash flow
- 37
Latest quarter · Q3 FY2020
Millions- Total revenues
- 115
- Gross profit
- 69
- Operating income
- 12
- Net income
- 7
- Free cash flow
- 11
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2016 to FY2019
- +28.2%
- Revenue, 5 yearsFY2014 to FY2019
- +21.4%
- Net income, 5 yearsFY2014 to FY2019
- n/m
BIOTELEMETRY, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2019 | FY2018 | Change | Source |
|---|---|---|---|---|
| Revenue | $439.1 million | $399.5 million | +9.9% | 10-K 2020-02-28 · proof |
| Gross profit | $274.3 million | $250.5 million | +9.5% | 10-K 2020-02-28 · proof |
| Operating income | $52.8 million | $49.8 million | +5.9% | 10-K 2020-02-28 · proof |
| Net income | $29.8 million | $41.9 million | -28.7% | 10-K 2020-02-28 · proof |
| Cash from operating activities | $67.6 million | $72.7 million | -7.1% | 10-K 2020-02-28 · proof |
| Free cash flow | $36.8 million | $48.1 million | -23.4% | 10-K 2020-02-28 · proof |
| Total assets | $685.7 million | $586.8 million | +16.9% | 10-K 2020-02-28 · proof |
| Total liabilities | $318.8 million | $276.3 million | +15.4% | 10-K 2020-02-28 · proof |
| Cash and cash equivalents | $68.6 million | $80.9 million | -15.2% | 10-K 2020-02-28 · proof |
| Total debt | $194.7 million | $198.5 million | -2% | 10-K 2020-02-28 · proof |
- What was BIOTELEMETRY, INC.'s revenue in fiscal 2019?
- BIOTELEMETRY, INC. reported revenue of $439.1 million for fiscal 2019 (the year ended Dec 31, 2019), against $399.5 million the year before (+9.9%). Source: the 10-K filed with the SEC on Feb 28, 2020. SEC
- What was BIOTELEMETRY, INC.'s gross profit in fiscal 2019?
- BIOTELEMETRY, INC. reported gross profit of $274.3 million for fiscal 2019 (the year ended Dec 31, 2019), against $250.5 million the year before (+9.5%). Source: the 10-K filed with the SEC on Feb 28, 2020. SEC
- What was BIOTELEMETRY, INC.'s operating income in fiscal 2019?
- BIOTELEMETRY, INC. reported operating income of $52.8 million for fiscal 2019 (the year ended Dec 31, 2019), against $49.8 million the year before (+5.9%). Source: the 10-K filed with the SEC on Feb 28, 2020. SEC
- What was BIOTELEMETRY, INC.'s net income in fiscal 2019?
- BIOTELEMETRY, INC. reported net income of $29.8 million for fiscal 2019 (the year ended Dec 31, 2019), against $41.9 million the year before (-28.7%). Source: the 10-K filed with the SEC on Feb 28, 2020. SEC
- What was BIOTELEMETRY, INC.'s cash from operating activities in fiscal 2019?
- BIOTELEMETRY, INC. reported cash from operating activities of $67.6 million for fiscal 2019 (the year ended Dec 31, 2019), against $72.7 million the year before (-7.1%). Source: the 10-K filed with the SEC on Feb 28, 2020. SEC
- What was BIOTELEMETRY, INC.'s free cash flow in fiscal 2019?
- BIOTELEMETRY, INC. reported free cash flow of $36.8 million for fiscal 2019 (the year ended Dec 31, 2019), against $48.1 million the year before (-23.4%). Source: the 10-K filed with the SEC on Feb 28, 2020. SEC
- What are BIOTELEMETRY, INC.'s total assets?
- As of Dec 31, 2019, BIOTELEMETRY, INC. reported total assets of $685.7 million, against $586.8 million a year earlier (+16.9%). Source: the 10-K filed with the SEC on Feb 28, 2020. SEC
- What are BIOTELEMETRY, INC.'s total liabilities?
- As of Dec 31, 2019, BIOTELEMETRY, INC. reported total liabilities of $318.8 million, against $276.3 million a year earlier (+15.4%). Source: the 10-K filed with the SEC on Feb 28, 2020. SEC
- What are BIOTELEMETRY, INC.'s cash and cash equivalents?
- As of Dec 31, 2019, BIOTELEMETRY, INC. reported cash and cash equivalents of $68.6 million, against $80.9 million a year earlier (-15.2%). Source: the 10-K filed with the SEC on Feb 28, 2020. SEC
- What is BIOTELEMETRY, INC.'s total debt?
- As of Dec 31, 2019, BIOTELEMETRY, INC. reported total debt of $194.7 million, against $198.5 million a year earlier (-2%). Source: the 10-K filed with the SEC on Feb 28, 2020. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1574774&period_type=annual&limit=5"Information only, not investment advice.